425: Strive Updates on Semler Scientific Merger

Strive, Inc. posted a communication on X.com regarding its proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.

Summary

• Strive, Inc. issued a communication on X.com on November 12, 2025, concerning its proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Forward-looking statements include expectations for the combined company's future financial performance, strategic and financial benefits, timing of closing, and successful integration.
• The filing emphasizes that actual results could differ materially due to various risks and uncertainties.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary communication regarding a proposed merger, outlining forward-looking statements and associated risks. It does not present new positive or negative financial results, maintaining a neutral sentiment.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits for the combined company.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various circumstances.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all, potentially delaying or preventing the closing.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction or future operations.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, potentially due to changes in Bitcoin treasury strategies, risks associated with Bitcoin and other digital assets, general economic conditions, or regulatory changes.
• The integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• The proposed transaction could be more expensive or take longer to complete than anticipated due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and other opportunities during the transaction process.
• Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction will cause dilution for existing shareholders.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur following the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction or shareholder value.

Future Outlook

The future outlook for the combined company is characterized by anticipated strategic and financial benefits from the proposed transaction, including improved financial performance and successful business integration. However, this outlook is subject to significant risks and uncertainties, including those related to the timing of the closing and the realization of expected synergies.

Management Comments

• Management's opinions and judgments about future events are based on assumptions that are subject to inherent risks and uncertainties, which could cause actual results to differ materially from anticipated results.

Industry Context

This announcement is a company-specific event related to a proposed merger and does not provide broader industry trend analysis. However, the mention of Bitcoin treasury strategies and digital assets suggests an evolving financial strategy that could be influenced by broader trends in digital asset adoption and regulation within the financial sector.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock for the merger.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes in business relationships due to the announcement or completion of the proposed transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available for important information about the companies and the transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, risk factors, corporate governance, Bitcoin treasury, digital assets